Currently, we are able to offer a full range of services for non-IgG development, such as antibody synthesis, purification, characterization, modification, etc. We offer promising treatments for esophagus carcinoma from the IgM class of therapeutic antibodies.

A dangerous cancer that develops in the esophagus, a tube-like organ that connects your throat to your stomach, is called esophageal cancer (EC). As far as mortality and prognosis are concerned, EC has become a serious health problem. According to the cells involved, EC is divided into numerous forms, including esophageal adenocarcinoma (EAC), the most prevalent variety in the United States; squamous cell carcinoma (SCC), the most prevalent type worldwide; and other uncommon varieties. Smoking, binge drinking, and Barrett's esophagus (BE) are all known to raise the risk of EC. Typical signs of EC include weight loss and unpleasant or difficult swallowing.